Glucotrack (GCTK) Non-Current Debt (2024 - 2025)

Glucotrack (GCTK) posted Non-Current Debt of $227000.0 for Q3 2025, up 2.71% on a QoQ basis from $221000.0 in Q2 2025.

Glucotrack (GCTK) Non-Current Debt (2024 - 2025) Analysis & Trends

Glucotrack's Non-Current Debt history runs 2 years deep, the most recent figure standing at $227000.0 for Q3 2025.

Quarterly Non-Current Debt changed N/A year-over-year to $227000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $227000.0 (changed N/A YoY) and the FY2024 annual result came in at $203000.0, changed N/A from the prior year.
Non-Current Debt was $227000.0 for Q3 2025 at Glucotrack, up from $221000.0 in the prior quarter.
Across five years, Non-Current Debt topped out at $227000.0 in Q3 2025 and bottomed at $201000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	4.16 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	14.71 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	12.50 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	404.17 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	202.90 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	1.86 Bn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	4.58 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	-
10	Glucotrack	33.48	-7.38 Mn	-	-

Download Data